1/16
10:40 am
syre
Spyre Therapeutics (NASDAQ:SYRE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $70.00 price target on the stock.
Low
Report
Spyre Therapeutics (NASDAQ:SYRE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $70.00 price target on the stock.
1/16
10:24 am
syre
Rating for SYRE
Low
Report
Rating for SYRE
12/19
05:58 am
syre
Spyre Therapeutics (NASDAQ:SYRE) was upgraded by analysts at Mizuho to a "strong-buy" rating.
Low
Report
Spyre Therapeutics (NASDAQ:SYRE) was upgraded by analysts at Mizuho to a "strong-buy" rating.
12/19
05:58 am
syre
Spyre Therapeutics (NASDAQ:SYRE) was upgraded by analysts at Mizuho to a "strong-buy" rating.
Low
Report
Spyre Therapeutics (NASDAQ:SYRE) was upgraded by analysts at Mizuho to a "strong-buy" rating.
12/19
05:58 am
syre
Spyre Therapeutics (NASDAQ:SYRE) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.
Low
Report
Spyre Therapeutics (NASDAQ:SYRE) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.
12/18
04:28 am
syre
Rating for SYRE
Low
Report
Rating for SYRE
12/18
04:28 am
syre
Rating for SYRE
Low
Report
Rating for SYRE
12/17
04:08 pm
syre
Spyre Therapeutics initiated with an Outperform at Mizuho
Low
Report
Spyre Therapeutics initiated with an Outperform at Mizuho
12/17
04:08 pm
syre
Spyre Therapeutics initiated with an Outperform at Mizuho
Low
Report
Spyre Therapeutics initiated with an Outperform at Mizuho
12/17
10:10 am
syre
Rating for SYRE
Low
Report
Rating for SYRE
12/17
10:10 am
syre
Rating for SYRE
Low
Report
Rating for SYRE
12/17
07:06 am
syre
Spyre Therapeutics (NASDAQ:SYRE) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.
Low
Report
Spyre Therapeutics (NASDAQ:SYRE) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.
12/17
06:01 am
syre
Spyre Therapeutics initiated with a Buy at Citi
Low
Report
Spyre Therapeutics initiated with a Buy at Citi